Skip to content
Study details
Enrolling now

3-5 FrAction Stereotactic Body Radiation Therapy for Palliation of Head and Neck Squamous Cell Carcinoma: the FAST Phase II Randomized Trial

M.D. Anderson Cancer Center
NCT IDNCT05674396ClinicalTrials.gov data as of Apr 2026
Phase

Phase 2

Target enrollment

108

Study length

about 4.3 years

Ages

18+

Locations

1 site in TX

What this study is about

This trial is testing if a new type of radiation treatment (stereotactic body radiotherapy or SBRT) can safely deliver high doses of radiation to head and neck squamous cell carcinoma tumors in less time than traditional methods. The goal is to determine if this advanced technique provides effective palliation for patients with this cancer.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Receive Stereotactic body radiotherapy
  • 2.Receive Traditional Palliation

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
All receive treatment

Everyone gets the investigational treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Primary: M. D. Anderson Symptom Inventory - Head & Neck (MDASI-HN) Questionnaires

Procedures

radiation

Body systems

Oncology